CHRU contributes to global infectious diseases research
The Clinical HIV Research Unit (CHRU) is a division of the Wits Health Consortium, a wholly-owned company of the Faculty of Health Sciences at the University of the Witwatersrand (Wits).
CHRU is affiliated to the Wits Faculty of Health Sciences Research Office.
Our multidisciplinary team collaborates with international networks and sponsors to contribute to global research. CHRU studies have advanced national (South Africa’s National Department of Health) and international (World Health Organisation) treatment guidelines.
With four clinical research sites across South Africa, all our studies comply with the highest ethical standards and regulations.
Dynamic team of scientists and professionals
The Clinical HIV Research Unit (CHRU) is home to a dynamic team of professionals who bring over two decades of clinical trial experience to the unit. They include scientists/principal investigators, medical officers, study coordinators, healthcare workers, pharmacists, counsellors and staff experienced in clinical trial operations - data management, quality assurance and regulatory.
Collaborative research contributes to knowledge base
The Clinical HIV Research Unit (CHRU) has a well-established track record of ongoing funding from multiple sources to support its research activities and technical assistance. This enables strong collaborations for clinical trials.
Communities central to clinical trials
Communities are central to the success of the studies undertaken by the Clinical HIV Research Unit (CHRU).
Most clinical trial participants live close to CHRU’s four clinical research sites.
Find out more
1. Participate in a study.
2. Support our community outreach.
3. Find out more about our research.